Company Leadership

Douglas Hay, PhD

Douglas Hay, PhD

 
Elizabeth Berezovsky, PhD

Elizabeth Berezovsky, PhD

 
Wade Lange

Wade Lange

Douglas Hay, Project Director

Douglas Hay is a pharmaceutical executive with more than 20 years of experience in drug discovery with GlaxoSmithKline. Dr. Hay has particular experience in respiratory and inflammatory disease therapeutics and was most recently Vice President of the COPD Drug Discovery group within the Respiratory & Inflammation Centre of Excellence for Drug Discovery.

Dr. Hay received his PhD in Physiology and Pharmacology from the University of Strathclyde, Scotland.

 

 

Elizabeth Berezovsky, Project Manager

Elizabeth Berezovsky has over 10 years of experience in chemistry and the life sciences . Prior to joining Allinaire, Dr. Berezovsky was a postdoctoral fellow at the Cleveland Clinic, where she led a research effort to explore the relationships between metabolism, cellular stress, and healthy aging. She has also served as a technical adviser to NemaMetrix, a biotechnology start-up company.

Dr. Berezovsky received her PhD in Chemistry from Harvard University.

 

 

WADE LANGE, FOUNDER & SENIOR ADVISER

Wade Lange is an experienced biotech entrepreneur having spent over 30 years in the pharmaceutical industry. Starting his career in new product planning and market research at Lilly, Mr. Lange has over 10 years of experience leading university start-ups as CEO including ImmuneWorks, a pulmonary disease focused company which has progressed into the clinical trial stage. He currently leads NeuroFx, a regenerative medicine startup focused on treatment of neurological disorders.

Mr. Lange received his Pharmacy and Industrial Administration degrees from Purdue University.